chronic heart failure/high blood pressure therapy (Lead Pharma)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namechronic heart failure/high blood pressure therapy (Lead Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLead Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLead Pharma
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A